|
Volumn 165, Issue 1, 2001, Pages 104-107
|
Medical versus surgical androgen suppression therapy for prostate cancer: A 10-year longitudinal cost study
a a a |
Author keywords
Androgen antagonists; Costs and cost analysis; Gonadorelin; Orchiectomy; Prostatic neoplasms
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIANDROGEN;
BICALUTAMIDE;
DIETHYLSTILBESTROL;
FLUTAMIDE;
GONADORELIN AGONIST;
GOSERELIN;
LEUPRORELIN;
NILUTAMIDE;
PROSTATE SPECIFIC ANTIGEN;
ARTICLE;
CANCER SURVIVAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COST;
HUMAN;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MALE;
ORCHIECTOMY;
OUTPATIENT;
PATIENT SATISFACTION;
PREVALENCE;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
TREATMENT OUTCOME;
|
EID: 0034747655
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1097/00005392-200101000-00026 Document Type: Article |
Times cited : (42)
|
References (21)
|